Modelling Forced Vital Capacity in Idiopathic Pulmonary Fibrosis: Optimising Trial Design

INTRODUCTION: Forced vital capacity is the only registrational endpoint in idiopathic pulmonary fibrosis clinical trials. As most new treatments will be administered on top of standard of care, estimating treatment response will become more challenging. We developed a simulation model to quantify va...

Full description

Saved in:
Bibliographic Details
Published in:Adv Ther
Main Authors: Santermans, Eva, Ford, Paul, Kreuter, Michael, Verbruggen, Nadia, Meyvisch, Paul, Wuyts, Wim A., Brown, Kevin K., Lederer, David J., Byrne, Adam J., Molyneaux, Philip L., Sivananthan, Arunon, Moor, Catharina C., Maher, Toby M., Wijsenbeek, Marlies
Format: Artigo
Language:Inglês
Published: Springer Healthcare 2019
Subjects:
Original Research
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822798/
https://ncbi.nlm.nih.gov/pubmed/31565781
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12325-019-01093-3
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items